Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications use pharmacological therapies hospitalized covid 19 patients ��� literature review
… surveys and observational studies can help you, your patients, regulators, and prescribers understand the real-world use, value, and safety of your products. Observational … and retention Statistical analysis plans Reports and publications Data Collection and Management Depending upon …
… of the health and economic impact of NVX-CoV2373 as a COVID-19 booster vaccine option for adults in the United States. …
… and application of patient-reported outcome measures for use in clinical research. She joins RTI-HS after nine years … efforts to mitigate the impact of the coronavirus (COVID-19) pandemic in clinical and non-clinical populations. Her …
… Considerations for planning safety surveillance studies of COVID-19 vaccines Alicia Gilsenan, PhD, FISPE Vice President, …
… ( CT)-based methods for selecting ischemic stroke patients for intravenous recombinant tissue plasminogen … clinical trials. We obtained model inputs from published literature, clinical trial data, standard US costing sources, …
… decreases in the efficacy of platelets, which meant that patients needed significantly more PC units for transfusion …
… and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.” While its title suggests … measured by the PRO instrument should be meaningful to patients. Consideration should also be given to aspects of a … – this expands the usual practice of evidence derived from literature review, KOL input, and qualitative research with …
15th European Public Health Conference 2022 (EPH) Share on: Wednesday, November 9 - Saturday, November 12, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 15th European Public Health Conference …
… treatments, adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle … few types of outcomes. The introduction of newer targeted therapies has led to gaps in evidence —evidence needed to … Overall survival Adverse events Healthcare resource use and costs Study results highlighted the following …
… and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis in the …